Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Pharmacist-led pain management in home-based cancer patients under the medical consortium model: a prospective randomized controlled trial.
Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo evaluate the effectiveness of pharmacist-led medication therapy management services (MTMs) in managing cancer pain for home-based patients under a medical consortium model.
methodsA prospective randomized controlled trial was conducted involving 100 discharged cancer patients with moderate-to-severe pain. Participants were randomly assigned to either the MTMs intervention group or the conventional care group. Outcome measures, including pain scores, pain relief levels, medication adherence, and anxiety levels, were assessed at 24 h after admission (baseline), 7 days, 1 month, and 3 months of follow-up.
resultsAfter 3 months, both groups exhibited significant reductions in pain scores compared to the 24-h baseline (P < 0.01). However, the intervention group demonstrated significantly lower pain scores (3.54 ± 0.76 vs 4.50 ± 1.18) and higher pain relief rates (CR + PR: 36.0% vs 12.0%). The proportion of patients with poor adherence in the intervention group was significantly lower than that of the control group (P < 0.01), and the improvement rate in medication adherence was significantly higher (50% vs 6%, P < 0.01). Furthermore, the intervention group showed a lower level of anxiety (P < 0.01) and a greater improvement in anxiety (38% vs 12%, P < 0.01).
conclusionThe implementation of standardized MTMs by pharmacists within the medical consortium effectively extended pharmaceutical care to the home setting. This intervention improved pain relief, enhanced medication adherence, and reduced anxiety among cancer pain patients; these findings support the potential for broader clinical application of this pharmacist-led model within integrated healthcare systems.
Indexed as
Identifiers
41400690What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.